Management of Sickle Cell Disease in Primary Care

Clinical Pediatrics

Volumn 42, Issue 9, 2003, Pages 753-761

  Wilson, Robert Edward ^a   Krishnamurti, Lakshmanan ^b   Kamat, Deepak ^c  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; BILIRUBIN; CEFTRIAXONE; CODEINE; ERYTHROMYCIN ETHYLSUCCINATE; ERYTHROPOIETIN; FOLIC ACID; HEMOGLOBIN; HYDROXYUREA; IBUPROFEN; IMMUNOGLOBULIN; INFLUENZA VACCINE; KETOROLAC; MACROLIDE; MENINGOCOCCUS VACCINE; MORPHINE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYGEN; PARACETAMOL; PENICILLIN V POTASSIUM; PNEUMOCOCCUS CONJUGATED VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PPV 23; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL PAIN; ACUTE CHEST SYNDROME; ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; APLASTIC ANEMIA; BACTERIAL INFECTION; BLOOD CELL COUNT; BLOOD VESSEL OCCLUSION; BONE MARROW APLASIA; BONE PAIN; BREAST FEEDING; CHILD; CHOLELITHIASIS; CLINICAL FEATURE; DACTYLITIS; DIAGNOSTIC PROCEDURE; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE SEVERITY; DRUG CHOICE; DRUG DEPENDENCE; DRUG HYPERSENSITIVITY; ELECTROPHORESIS; FEVER; GALLBLADDER DISEASE; GALLSTONE; HEMOGLOBIN ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNIZATION; INFECTION RISK; INFLUENZA; ISOELECTRIC FOCUSING; LABORATORY TEST; LIMB DISEASE; LIMB PAIN; MENINGOCOCCOSIS; NEWBORN; NEWBORN SCREENING; NOTE; NUTRITION; OXYGEN THERAPY; PAIN; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIAPISM; PRIMARY HEALTH CARE; SEIZURE; SICKLE CELL ANEMIA; SPLEEN DISEASE; SPLEEN SEQUESTRATION; STREPTOCOCCUS INFECTION; STROKE; TRANSCUTANEOUS OXYGEN MONITORING; URINALYSIS; VITAMIN SUPPLEMENTATION;

EID: 0344395098     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280304200901     Document Type: Note

References (32)

1. Pass KA, Lane PA, Fernhoff PM, et al. US newborn screening system guidelines 11: follow-up of children, diagnosis, management, and evaluation. Statement of the of Regional Networks for Genetic Services (CORN). J Pediatr 2000;137:S1-46.
2. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ. 1995;311:1600-1602.
3. Anonymous. Health supervision for children with sickle cell disease. Pediatrics. 2002;109:526-535.
4. Anonymous. The Management of Sickle Cell Disease. Bethesda, MD: National Institutes of Health. National Heart, Lung, and Blood Institute. Division of Blood Diseases and Resource; 2002.
5. Miller ST, Sleeper IA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000;342:83-89.
6. Frenette PS. Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol. 2002;9:101-106.
7. Anonymous. Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling in Newborns and Infants Clinical practice guideline 6. Rockville, MD: ahcpr, phs, US Department of HHS; 1993.
8. Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol. 1991;28:220-226.
9. Pegelow CH, Colangelo L, Steinberg M, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997;102:171-177.
10. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997;42:699-704.
11. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5-11.
12. Adams RJ, Ohene-Frempong K, Wang W. Sickle cell and the brain. Hematology. 2001:31-46.
13. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362-366.
14. Overturf GD. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics. 2000;106:367-376.
15. Rodriguez-Cortes HM, Griener JC, et al. Plasma homocysteine levels and folate status in children with sickle cell anemia. J Pediatr Hematol Oncol. 1999;21:219-223.
16. Kennedy TS, Fung EB, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. J Pediatr Hematol Oncol. 2001;23:165-169.
17. Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr. 1986;109:579-585.
18. Williams LL, Wilimas JA, Harris SC, Day SW, Dancy RM, Wang WC. Outpatient therapy with ceftriaxone and oral cefixime, for selected febrile children with sickle cell disease. J Pediatr Hematol Oncol. 1996;18:257-261.
19. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325:11-16.
20. Anonymous. Guideline for the Management of Acute and Chronic Pain in Sickle Cell Disease. APS clinical practice guideline; no. 1. Glenview IL: American Pain Society (APS), 1999.
21. Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med. 1995;333:699-703.
22. Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340:1021-1030.
23. Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea, in children and young adults with sickle cell disease. Blood. 2001;97:3628-3632.
24. Wang WC, Helms RW, Lynn HS, et al. Effect of hydroxyurea, on growth in children with sickle cell anemia: results of the H-UG-KIDS Study. J Pediatr. 2002;140:225-229.
25. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342:1855-1865.
26. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995;333:206-213.
27. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol. 2001;38:14-22.
28. Ohene-Frempong K. Indications for red cell transfusion in sickle cell disease. Semin Hematol. 2001;38:5-13.
29. Ohene-Frempong K. Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. Semin Hematol. 1991;28:213-219.
30. Mantadakis E, Cavender JD, Rogers ZR, Ewalt DH, Buchanan GR. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol. 1999;21:518-522.
31. Adeyoju AB, Olujohungbe AB, Morris J, et al. Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study. BJU Int. 2002;90:898-902.
32. Mantadakis E, Ewalt DH, Cavender JD, Rogers ZR, Buchanan GR. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood. 2000;95:78-82.